These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12145300)

  • 1. Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations.
    Prioleau C; Visiers I; Ebersole BJ; Weinstein H; Sealfon SC
    J Biol Chem; 2002 Sep; 277(39):36577-84. PubMed ID: 12145300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor.
    Rosendorff A; Ebersole BJ; Sealfon SC
    Brain Res Mol Brain Res; 2000 Dec; 84(1-2):90-6. PubMed ID: 11113535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor.
    Zhang M; Mizrachi D; Fanelli F; Segaloff DL
    J Biol Chem; 2005 Jul; 280(28):26169-76. PubMed ID: 15908694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants regulating expression of the high affinity leukotriene B4 receptor: involvement of dileucine motifs and alpha-helix VIII.
    Gaudreau R; Beaulieu ME; Chen Z; Le Gouill C; Lavigne P; Stanková J; Rola-Pleszczynski M
    J Biol Chem; 2004 Mar; 279(11):10338-45. PubMed ID: 14688279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor.
    Urizar E; Claeysen S; Deupí X; Govaerts C; Costagliola S; Vassart G; Pardo L
    J Biol Chem; 2005 Apr; 280(17):17135-41. PubMed ID: 15722344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398.
    Fanelli F; Verhoef-Post M; Timmerman M; Zeilemaker A; Martens JW; Themmen AP
    Mol Endocrinol; 2004 Jun; 18(6):1499-508. PubMed ID: 15016840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively active mutants of 5-HT4 receptors are they in unique active states?
    Claeysen S; Sebben M; Bécamel C; Parmentier ML; Dumuis A; Bockaert J
    EMBO Rep; 2001 Jan; 2(1):61-7. PubMed ID: 11252726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
    Martin SS; Boucard AA; Clément M; Escher E; Leduc R; Guillemette G
    J Biol Chem; 2004 Dec; 279(49):51415-23. PubMed ID: 15452107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation.
    Fritze O; Filipek S; Kuksa V; Palczewski K; Hofmann KP; Ernst OP
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2290-5. PubMed ID: 12601165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor.
    Leo LM; Al-Zoubi R; Hurst DP; Stephan AP; Zhao P; Tilley DG; Miess E; Schulz S; Abood ME; Reggio PH
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):731-748. PubMed ID: 35792570
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
    Pauwels PJ; Gouble A; Wurch T
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
    Xie J; Dernovici S; Ribeiro P
    J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6.
    Han M; Smith SO; Sakmar TP
    Biochemistry; 1998 Jun; 37(22):8253-61. PubMed ID: 9609722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate acts as a partial inverse agonist to metabotropic glutamate receptor with a single amino acid mutation in the transmembrane domain.
    Yanagawa M; Yamashita T; Shichida Y
    J Biol Chem; 2013 Apr; 288(14):9593-9601. PubMed ID: 23420844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis.
    Impellizzeri AA; Pappalardo M; Basile L; Manfra O; Andressen KW; Krobert KA; Messina A; Levy FO; Guccione S
    Front Behav Neurosci; 2015; 9():92. PubMed ID: 26005408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor.
    Sealfon SC; Chi L; Ebersole BJ; Rodic V; Zhang D; Ballesteros JA; Weinstein H
    J Biol Chem; 1995 Jul; 270(28):16683-8. PubMed ID: 7622478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptors.
    Claeysen S; Sebben M; Bécamel C; Eglen RM; Clark RD; Bockaert J; Dumuis A
    Mol Pharmacol; 2000 Jul; 58(1):136-44. PubMed ID: 10860935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
    Kristiansen K; Kroeze WK; Willins DL; Gelber EI; Savage JE; Glennon RA; Roth BL
    J Pharmacol Exp Ther; 2000 Jun; 293(3):735-46. PubMed ID: 10869371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.